- Research and Projects
- Get Involved
Social prescribing has the potential to address many of the factors that perpetuate illness, decrease quality of life and add to health care costs – such as social isolation, inactivity and smoking. It has expanded the options available to GPs who have patients requiring financial, housing and other social advice alongside their medical care.
In a piece published in BMJ Opinion, PenCLAHRC Research Fellow Dr Kerryn Husk warns that, in order for social prescribing to reach its full potential and make a true difference to patients, more needs to be done to understand what works, for whom, and in what circumstances.
A large-scale trial led by the University of Exeter, presented at the international Alzheimer’s Association International Conference (AAIC) 2017 on Tuesday July 18, has found that cognitive rehabilitation leads to people seeing satisfying progress in areas that enable them to maintain their functioning and independence.
The Goal-oriented Cognitive Rehabilitation in Early-stage Alzheimer’s and Related Dementias: Multi-centre Single-blind Randomised Controlled Trial (GREAT) trial involved 475 people across eight sites in England and Wales. Half of them received ten cognitive rehabilitation sessions over three months, and the other half did not. The group receiving the therapy then took part in four ‘top-up’ sessions...Read more
It is widely acknowledged that care provided by the NHS and other services should be person-centred - that is, centred on the individual and responsive to their needs. One way of achieving this is through a better understanding of the patient’s experience of care and a PenCLAHRC project has been the first to put together a guide for commissioners on this topic.
The new guide was compiled by PenCLAHRC researchers and patient-centred coordinated care experts based at Plymouth University Peninsula Schools of Medicine and Dentistry, with support from NHS England, the Coalition for Collaborative Care, and the South West Academic Health...Read more
“With the HSMA programme, we have developed an exciting new way for the NHS to engage with the power and potential of simulation modelling in a meaningful way. It means that NHS organisations across the region can build their in-house capacity to build models that inform decisions whilst seeing real impact for the organisation.
Dan Chalk, Research Fellow in the PenCHORD team and lead for the HSMA programme
To mark the end of the first year of our Health Service Modelling Associates (HSMA) programme, we’ve launched a new website to showcase the impacts that this innovative scheme has had on NHS Trusts across the...Read more